Our Team

As a non-profit organization, ACRES is led by its Executive Office and Board of Directors. These individuals are internationally-recognized and respected individuals who are champions for innovation and integration in clinical research.

The ACRES Alliance is a consortium of like-minded organizations and stakeholders that share the ACRES vision and bring their expertise to the ACRES initiatives.

Board of Directors

Greg Koski, PhD, MD


Co-Founder & President / Chief Executive Officer, ACRES
Senior Scientist, James Mongan Institute for Health Policy
Associate Professor of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Briggs Morrison MD

Board Member

CEO, Syndax Pharmaceuticals
Managing Director, MPM Capital

Eve E. Slater MD

Board Member

Associate Professor of Clinical Medicine, Columbia University; former Senior Vice President, Worldwide Policy at Pfizer; former Senior Vice President for External Policy at Merck; former Assistant Secretary for Health, US Department of Health and Human Services

Rebecca Kush PhD

Board Member

Founder and President, Clinical Data Interchange Standards Consortium (CDISC)

Brendan Buckley, PhD

Board Member

Former Chief Medical Officer of ICON; Chairperson, Fighting Blindness; Director, European Collaborative Centre for Clinical Trials in Rare Diseases and Irish Medicines Board; EMA Scientific Advisory Committee on Diabetes and Metabolism

Bob Stewart

Board Member

CEO, EXOCHAIN, CORP; Chief Technology Officer, ACRES;
Recently, COO and Board Member, Sonavation; Formerly, CTO, EMC Global Security Group; CTO, Verified Person; Co-founder & CTO, CyberMedica; CTO, CMGI Incubator; CTO, Motorola, Internet and Networking Group

Badhri Srinivasan, ABD, BioStatistics

Board Member

Head, Global Development Operations, Novartis; Previously, CEO and co-founder of Remarque Systems (technology); SVP and Global Head, Data and Safety Monitoring, Quintiles; VP of Enterprise Analytics and Business Process Management, Quintiles Innovation

Margaret T Long

Board Member

Principal, Willow Pointe Consulting Group. Former VP, Business Communications and Stakeholder Engagement and VP, Government Advocacy at ASTELLAS; Director, State Government Affairs at NOVARTIS. Medical Marketing and Media (MM&M) Hall of Femme Award 2017.

Henry D. Levy

Board Member

Veeva Systems, Chief Strategy Officer; Previously, Chief Commercial Officer, PPD, Inc;
Accenture LLP, Global Managing Director, Accenture Life Sciences R&D

Ranga Krishnan

Board Member

Dean, Duke-National University of Singapore Graduate School of Medicine Professor and Chair, Department of Psychiatry, Duke University School of Medicine

Executive Office

Greg Koski, PhD, MD

Co-Founder & President / Chief Executive Officer

Senior Scientist, James Mongan Institute for Health Policy Associate Professor of Anesthesia,  Massachusetts General Hospital Harvard Medical School, Boston, MA

Matthew D. Whalen, PhD

Chief Operating Officer

Principal, IMPACT LLC, Gambrills, MD; Co-Founder, Chesapeake IRB

Mary F. Tobin, PhD

Chief Strategy Officer & Special Advisor to President/CEO

Founder and Managing Director, IMPACT LLC, Gambrills, MD; Formerly: Outside Lead Consultant, OPM; University of Maryland, College Park University Honors Program

Diana Howard

Director Administration and Finance

Formerly, Financial Director, C. R. Smith Museum, American Airlines

Bob Stewart

Chief Technology Officer

Formerly COO and Board Member, Sonavation.

Brian Edwards, MD

VP, Safety & Pharmacovigilance

Chair of the Site Accreditation and Standards Initiative (SASI); CEO Quality Management Institute

Daniel O'Connor

VP, Site Development and Support

Principal Consultant, NDA Regulatory Science Ltd, Surrey, UK Director of International; Society of Pharmacovigilance Secretariat Ltd, UK

Beat Widler

VP, Auditing & Monitoring Systems

President and Founder, TrialSiteNews LLC

Sandor Kerpel-Fronius, MD

VP, Global Development

Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland

Dennis J. LaCroix, Esq.

General Counsel

Sr Scientific Advisor /Professor, Clinical Pharmacology, Semmelweis University, Budapest, Hungary
General Director, Hungarian National Institute of Pharmacy;
Serves on Executive Board of the IMI-PharmaTrain.

Ex-Officio Board of Directors

Beat Widler

Ex-Officio Director

Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland

Andrew Olmstead

Ex-Officio Director

Executive Vice President, Research Dataware, LLC, (a WIRB-Copernicus Group Company), Cambridge, MA